| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CALL FOR PAPERS
Metabolic Syndrome
Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi
Submitted 26 April 2005 ; accepted in final form 8 September 2005
These studies tested the hypothesis that in obese Zucker rats (OZRs), a model of metabolic syndrome, the impaired functional vasodilation is due to increased thromboxane receptor (TP)-mediated vasoconstriction and/or decreased prostacyclin-induced vasodilation. Spinotrapezius arcade arterioles from 12-wk-old lean (LZR) and OZR were chosen for microcirculatory observation. Arteriolar diameter (5 LZR and 6 OZR) was measured after 2 min of muscle stimulation in the absence or presence of 1 µM SQ-29548 (TP antagonist). Additionally, arteriolar diameter (6 for each group) was measured after application of iloprost (prostacyclin analog; 0.28, 2.8, and 28 µM), arachidonic acid (10 µM), and sodium nitroprusside (0.1, 1, and 10 µM) in the absence or presence of 1 µM SQ-29548. A 10 µM concentration of adenosine was used to induce a maximal dilation. Basal diameters were not different between LZRs and OZRs. Functional hyperemia and arachidonic acid-mediated vasodilations were significantly attenuated in OZR compared with LZR, and treatment with 1 µM SQ-29548 significantly enhanced the dilations in OZRs, although it had no effect in LZRs. Vasodilatory responses to iloprost and sodium nitroprusside (1 and 10 µM) were significantly reduced in OZR. Adenosine-mediated vasodilation was not different between groups. These results suggest that the impaired functional dilation in the OZR is due to an increased TP-mediated vasoconstriction and a decreased PGI2-induced vasodilation.
obese Zucker rat; prostacyclin; thromboxane; vasoconstriction
This article has been cited by other articles:
|
|
 |
|
  L. Xiang and R. L. Hester Adipocyte-derived factor reduces vasodilatory capability in ob-/ob- mice Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H689 - H695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Frisbee, J. M. Hollander, R. W. Brock, H.-G. Yu, and M. A. Boegehold Integration of skeletal muscle resistance arteriolar reactivity for perfusion responses in the metabolic syndrome Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2009; 296(6): R1771 - R1782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Hodnett, J. A. Dearman, C. B. Carter, and R. L. Hester Attenuated PGI2 synthesis in obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R715 - R721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Goodwill, M. E. James, and J. C. Frisbee Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1522 - H1528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xiang, J. Dearman, S. R. Abram, C. Carter, and R. L. Hester Insulin resistance and impaired functional vasodilation in obese Zucker rats Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1658 - H1666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xiang, J. S. Naik, S. R. Abram, and R. L. Hester Chronic hyperglycemia impairs functional vasodilation via increasing thromboxane-receptor-mediated vasoconstriction Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H231 - H236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Frisbee Vascular adrenergic tone and structural narrowing constrain reactive hyperemia in skeletal muscle of obese Zucker rats Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2066 - H2074. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
